Skip to main content

Pancreatic Cancer Clinical Trials

Review the pancreatic cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 276-300 of 307

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients with Cancer
Status: Active
Location: Virginia K Crosson Cancer Center, Fullerton, California
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Status: Active
Location: 2 locations
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Status: Active
Location: See ClinicalTrials.gov
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection
Status: Active
Location: 727 locations
Biomarker Analysis in Improving Screening in Patients with or at High Risk of Developing Pancreatic Cancer
Status: Active
Location: 9 locations
A Longitudinal Cohort Study to Identify Clinical and Blood Markers of Early Pancreas Cancer
Status: Active
Location: University of Nebraska Medical Center, Omaha, Nebraska
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Status: Active
Location: 205 locations
An Investigational Scan (Hyperpolarized Carbon-13 Pyruvate MRI) for Assessing Treatment Response in Patients with Locally Advanced or Metastatic Pancreatic Ductal Carcinoma
Status: Active
Location: University of California San Francisco, San Francisco, California
Association of Genomic Polymorphisms with Cancer Cachexia in Subjects with Pancreatic Adenocarcinoma
Status: Active
Location: 2 locations
Association of Plant-based Diet and Gut Microbiome Signature with Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Pancreatic Cancer Early Detection Consortium
Status: Active
Location: 23 locations
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Status: Active
Location: 12 locations
Biomarkers for the Early Detection, Surveillance, and Monitoring in Patients with Locally Advanced or Metastatic Pancreatic Cancer
Status: Active
Location: 9 locations
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Status: Active
Location: 7 locations
Biospecimen Resource for Pancreas Research
Status: Active
Location: 3 locations
Pancreas Disease and High-Risk Registry
Status: Active
Location: 3 locations
Pan-tumor MRD Study
Status: Active
Location: 2 locations
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
Status: Active
Location: UCHealth University of Colorado Hospital, Aurora, Colorado
EXoPERT EMERALD Clinical Study
Status: Active
Location: University of Hawaii Cancer Center, Honolulu, Hawaii
Identification of microRNAs in Cachexia in Patients with Pancreatic Cancer
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Exosome Biomarkers in Blood, Pancreatic Fluid, and Tissue Samples from Patients with Pancreatic Cancer Undergoing Surgery
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Prospective Study to Assess a Diagnostic Aid for Cancer
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Northwestern Ovarian Cancer Early Detection and Prevention Program
Status: Active
Location: Northwestern University, Chicago, Illinois